Evidence map›Paper›PMID 35214042›Full record

ArticlePharmaceutics2022

Self-Organized Nanoparticles of Random and Block Copolymers of Sodium 2-(Acrylamido)-2-methyl-1-propanesulfonate and Sodium 11-(Acrylamido)undecanoate as Safe and Effective Zika Virus Inhibitors.

Pawel Botwina, Magdalena Obłoza, Maria Zatorska-Płachta, Kamil Kamiński, Masanobu Mizusaki, Shin-Ichi Yusa, Krzysztof Szczubiałka, Krzysztof Pyrc, Maria Nowakowska

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Pawel BotwinaMicrobiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.ORCID 0000-0001-9006-1568
Magdalena ObłozaDepartment of Physical Chemistry, Faculty of Chemistry, Jagiellonian University, 30-387 Krakow, Poland.
Maria Zatorska-PłachtaDepartment of Physical Chemistry, Faculty of Chemistry, Jagiellonian University, 30-387 Krakow, Poland.
Kamil KamińskiDepartment of Physical Chemistry, Faculty of Chemistry, Jagiellonian University, 30-387 Krakow, Poland.ORCID 0000-0002-7421-6758
Masanobu MizusakiDepartment of Applied Chemistry, Graduate School of Engineering, University of Hyogo, 2167 Shosha, Himeji 671-2280, Japan.ORCID 0000-0003-4874-3500
Shin-Ichi YusaDepartment of Applied Chemistry, Graduate School of Engineering, University of Hyogo, 2167 Shosha, Himeji 671-2280, Japan.ORCID 0000-0002-2838-5200
Krzysztof SzczubiałkaDepartment of Physical Chemistry, Faculty of Chemistry, Jagiellonian University, 30-387 Krakow, Poland.ORCID 0000-0001-6612-1102
Krzysztof PyrcVirogenetics Laboratory of Virology, Malopolska Centre of Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.ORCID 0000-0002-3867-7688
Maria NowakowskaDepartment of Physical Chemistry, Faculty of Chemistry, Jagiellonian University, 30-387 Krakow, Poland.ORCID 0000-0001-6456-5463
Jagiellonian University · PLUniversity of Hyogo · JP

Funding

National Science Center 2016/21/B/NZ6/01307National Science Center 2017/27/B/ST5/01108
6 · The paper itself

Abstract

A series of anionic homopolymers, poly(sodium 2-(acrylamido)-2-methyl-1-propanesulfonate) (PAMPS) and amphiphilic copolymers of AMPS and sodium 11-(acrylamido)undecanoate (AaU), both block (PAMPS

Indexed as

amphiphilic copolymerssodium 11-(acrylamido)undecanoatesodium 2-(acrylamido)-2-methyl-1-propanesulfonateZika virus

Identifiers

PMID35214042
PMCPMC8876367
OpenAlexW4210545469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.